Month: August 2022

RT @ThomasCiullaMD: Excited to present on #suprachoroidal drug delivery at @Oph…

RT @ThomasCiullaMD: Excited to present on #suprachoroidal drug delivery at @OphthalmologyFF! After FDA approval of #Xipere, SC delivery be… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Now in print, in this month’s British Journal of Ophthalmolo…

RT @ThomasCiullaMD: Now in print, in this month’s British Journal of Ophthalmology: Extension study of the safety and efficacy of CLS-TA fo… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Dr Steven Yeh on Patients Treated With Xipere and Its Use Ov…


RT @ThomasCiullaMD: Dr Steven Yeh on Patients Treated With Xipere and Its Use Over the Long Term https://t.co/nWhm7CUCJP via @AJMC_Journal


Source by Thomas Ciulla, MD, MBA

Return to main website.

Excited to present on #suprachoroidal drug delivery at @OphthalmologyFF! After …

Excited to present on #suprachoroidal drug delivery at @OphthalmologyFF! After FDA approval of #Xipere, SC delivery became a reality. Now, #clinicaltrials involving SC delivery include a TKI, a steroid, a #genetherapy & a virus-like drug conjugate. #eyes https://t.co/SyafhDOM7l https://t.co/J7G54DeoOw Source by Thomas Ciulla, MD, MBA 

RT @RetinalPhys: Video in this article shows Dennis Marcus, MD, administering su…

RT @RetinalPhys: Video in this article shows Dennis Marcus, MD, administering suprachoroidal RGX-314 in a patient with diabetic retinopathy… Source by Thomas Ciulla, MD, MBA Return to main website.

Now in print, in this month’s British Journal of Ophthalmology: Extension study …


Now in print, in this month’s British Journal of Ophthalmology: Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA) https://t.co/jnWs2e0xOj


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: Just published @RetinalPhys: #Suprachoroidal Drug Delivery T…

RT @ThomasCiullaMD: Just published @RetinalPhys: #Suprachoroidal Drug Delivery Technology. After #Xipere’s approval, SC #drugdelivery is cl… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: It means a lot to be recognized by colleagues. I am honored …

RT @ThomasCiullaMD: It means a lot to be recognized by colleagues. I am honored to be named a “2022 Top Doctor”. Very grateful to work wit… Source by Thomas Ciulla, MD, MBA Return to main website.

RT @ThomasCiullaMD: Just published: This post hoc analysis compared #suprachoroi…


RT @ThomasCiullaMD: Just published: This post hoc analysis compared #suprachoroidal triamcinolone acetonide (CLS-TA) to other commonly avai…


Source by Thomas Ciulla, MD, MBA

Return to main website.

RT @ThomasCiullaMD: National physician survey on clinical practice patterns for …

RT @ThomasCiullaMD: National physician survey on clinical practice patterns for the treatment of noninfectious uveitis | IOVS | ARVO Journa… Source by Thomas Ciulla, MD, MBA Return to main website.